Drug breakthrough offers hope for advanced prostate cancer patients
Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...
Hosted on MSN22h
DNLI's Hunter Syndrome Drug Gets Breakthrough Therapy Designation
Denali Therapeutics Inc. DNLI announced that the FDA has granted Breakthrough Therapy Designation to its pipeline candidate, ...
Cure Today18h
FDA Grants BTD to the ADC GSK’227 in Relapsed/Refractory Osteosarcoma
The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...
Advanced tumours shrink in prostate cancer breakthrough
A breakthrough in prostate cancer treatment has seen a drug shrink tumours in advanced disease ...
Taiwan News3h
Tiziana Announces Reduction of Side Effects Commonly Seen with Discontinuation of GLP-1 Agonists with Nasal Anti-CD3
GLP-1 drugs, widely used for treating metabolic disorders, often face issues with long term tolerability, leading to side effects such as sarcopenia and bone density loss. These complications ...
Prostate cancer drug breakthrough NXP800 offers new hope for patients facing treatment resistance
The drug, known as NXP800, works by targeting the heat shock factor 1 (HSF1) pathway, a cellular protective mechanism that is ...
Denali: Despite ALS Primary Endpoint Failure, Possible Path Forward Remains
Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...
Cullinan Therapeutics' CLN-978 And Zipalertinib Look Promising In NSCLC
Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...
The Debrief20h
New Developments in Tesla Cybertruck Explosion Investigation Reveal Strange Emails Sent in Suspect’s Final Hours
This week, odd new details emerge as authorities continue to investigate the New Year's Day Tesla Cybertruck explosion in Las ...
Science Daily12h
New AI platform identifies which patients are likely to benefit most from a clinical trial
A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...
Sky22h
Ukraine latest: Russian bomb attack injures more than 100; US unveils final funding boost for Ukraine days before Trump takes office
But we'll be back tomorrow with more updates on the war in Ukraine. Here are the key lines from today: Outgoing US defence secretary Lloyd Austin announced a $500m (£407m) aid package for Ukraine ...